Conference call to discuss financial results and recent business highlights to take place on Wednesday, August 28, 2024, at 8:00…
Read More
I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business Updates
Completed divestiture of China operations Uliledlimab IND clearance paves the way for U.S. combination studies in first-line mNSCLC (CD73 antibody)…
Read More
